The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization.
Obatoclax belongs to a class of compounds known as BH3 mimetics which function as antagonists of Bcl-2 family apoptosis regulators. It has undergone extensive preclinical and clinical evaluation as a cancer therapeutic. Despite this, it is clear that obatoclax has additional pharmacological effects...
Main Authors: | Vasileios A Stamelos, Natalie Fisher, Harnoor Bamrah, Carolyn Voisey, Joshua C Price, William E Farrell, Charles W Redman, Alan Richardson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4780728?pdf=render |
Similar Items
-
Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma
by: Margarita Espona-Fiedler, et al.
Published: (2022-12-01) -
BH3 Mimetics in Hematologic Malignancies
by: Pavel Klener, et al.
Published: (2021-09-01) -
BH3 Mimetics for the Treatment of Prostate Cancer
by: Philipp Wolf
Published: (2017-08-01) -
The application of BH3 mimetics in myeloid leukemias
by: Narissa Parry, et al.
Published: (2021-02-01) -
BH3-mimetics: recent developments in cancer therapy
by: Paul A. Townsend, et al.
Published: (2021-11-01)